OncoImmune Archives · BioBuzz

Loading …

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/11/Copy-of-Copy-of-Featured-Images-3-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : November 23, 2020November 23, 2020 Published by : Chris Frew

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal